Thermopylae Holdings Ltd., 10% Owner at AbCellera Biologics Inc. (ABCL), bought 306,000 shares at $6.52 ($2.0M) on 2023-05-26, disclosed to the SEC on 2023-05-26.
Open-market purchase of $2.0M ABCL by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.52 | 153,000 | $998K | 50.0% |
| 2 | $6.52 | 153,000 | $998K | 50.0% |
| Total | $6.52 avg | 306,000 | $2.0M | 100% |
| Filing → |
| ABCL | BUY | 2025-03-11 | $1.5M | — | Filing → |
| ABCL | BUY | 2024-08-29 | $1.5M | — | Filing → |
| ABCL | BUY | 2022-12-20 | $1.7M | — | Filing → |